Welcome to CDC Stacks | Guidelines for biosafety laboratory competency - 11597 | Stephen B. Thacker CDC Library collection | Guidelines and Recommendations
Stacks Logo
Advanced Search
Select up to three search categories and corresponding keywords using the fields to the right. Refer to the Help section for more detailed instructions.
 
 
Help
Clear All Simple Search
Advanced Search
Guidelines for biosafety laboratory competency
  • Published Date:
    April 15, 2011
  • Status:
    current
  • Source:
    Morbidity and mortality weekly report. Supplements. 2011; 60 Suppl 2:1-23.
Filetype[PDF - 17.05 MB]


This document cannot be previewed automatically as it exceeds 5 MB
Please click the thumbnail image to view the document.
Guidelines for biosafety laboratory competency
Details:
  • Corporate Authors:
    Centers for Disease Control and Prevention (U.S.), Office of Surveillance, Epidemiology, and Laboratory Services., Epidemiology and Analysis Program Office ; CDC Strategic Planning Workgroup ; Association of Public Health Laboratories (U.S.)
  • Pubmed ID:
    21490563
  • Funding:
    US 60/CD 303019-22
  • Series:
    MMWR. Morbidity and mortality weekly report ; v. 60, suppl
  • Document Type:
  • Description:
    Introduction -- Methodology -- Guiding principles -- Competencies and skill domains -- Conclusion -- References -- Appendix A. Terms used in these guidelines -- Appendix B. Biosafety laboratory competency guidelines

    "These guidelines for biosafety laboratory competency outline the essential skills, knowledge, and abilities required for working with biologic agents at the three highest biosafety levels (BSLs) (levels 2, 3, and 4). The competencies are tiered to a worker's experience at three levels: entry level, midlevel (experienced), and senior level (supervisory or managerial positions). These guidelines were developed on behalf of CDC and the Association of Public Health Laboratories (APHL) by an expert panel comprising 27 experts representing state and federal public health laboratories, private sector clinical and research laboratories, and academic centers. They were then reviewed by approximately 300 practitioners representing the relevant fields. The guidelines are intended for laboratorians working with hazardous biologic agents, obtained from either samples or specimens that are maintained and manipulated in clinical, environmental, public health, academic, and research laboratories." - p. 1

    "This publication was made possible through the CDC-APHL Cooperative Agreement No. US 60/CD 303019-22. The findings and conclusions in this report are those of the authors and do not necessarily represent the official position of CDC or the Association of Public Health Laboratories."

  • Supporting Files:
    No Additional Files